SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-15-003034
Filing Date
2015-09-01
Accepted
2015-09-01 07:10:52
Documents
4
Period of Report
2015-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a51171580.htm 8-K 45961
2 EXHIBIT 4.1 a51171580ex4_1.htm EX-4.1 84103
3 EXHIBIT 10.1 a51171580ex10_1.htm EX-10.1 246094
4 EXHIBIT 99.1 a51171580ex99_1.htm EX-99.1 17557
  Complete submission text file 0001157523-15-003034.txt   395192
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 151086296
SIC: 2834 Pharmaceutical Preparations